Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unicycive Therapeutics, Inc.

0.6350
-0.0289-4.35%
Volume:597.33K
Turnover:397.78K
Market Cap:65.91M
PE:-1.30
High:0.6814
Open:0.6639
Low:0.6300
Close:0.6639
Loading ...

BRIEF-Unicycive Announces Q3 2024 Financial Results And Provides Business Update

Reuters
·
13 Nov 2024

Unicycive Therapeutics reports Q3 EPS (13c), consensus (15c)

TIPRANKS
·
13 Nov 2024

Unicycive Therapeutics Q3 Income From Operations USD -6.251 Million

THOMSON REUTERS
·
13 Nov 2024

Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

THOMSON REUTERS
·
13 Nov 2024

Unicycive Therapeutics Inc Q3 Shr View $-0.15 -- Lseg Ibes Data

THOMSON REUTERS
·
13 Nov 2024

Press Release: Unicycive Announces Third Quarter 2024 Financial Results and Provides Business Update

Dow Jones
·
13 Nov 2024

Unicycive Therapeutics Says FDA Accepts New Drug Application for Oxylanthanum Carbonate

MT Newswires Live
·
11 Nov 2024

Unicycive: FDA to Review Lead Drug Candidate for Hyperphosphatemia

Dow Jones
·
11 Nov 2024

Unicycive Therapeutics announces U.S. FDA acceptane for NDA for OLC

TIPRANKS
·
11 Nov 2024

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (Nda) for Oxylanthanum Carbonate (Olc) for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease on Dialysis

THOMSON REUTERS
·
11 Nov 2024

Unicycive Therapeutics Inc - Preparing for 2025 Commercial Launch of Olc

THOMSON REUTERS
·
11 Nov 2024

Unicycive Therapeutics Inc - FDA Sets Pdufa Action Date of June 28, 2025

THOMSON REUTERS
·
11 Nov 2024

Unicycive Therapeutics Announces U.S. FDA Acceptance of the New Drug Application (NDA) for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

GlobeNewswire
·
11 Nov 2024

Unicycive presents on development progress of oxylanthanum carbonate

TIPRANKS
·
28 Oct 2024

Unicycive Therapeutics Delivers Multiple Poster Presentations Highlighting Development Progress on Oxylanthanum Carbonate (OLC) and UNI-494 at the American Society of Nephrology (ASN) Kidney Week 2024

GlobeNewswire
·
28 Oct 2024

Unicycive Therapeutics, Inc. (NASDAQ:UNCY): Is Breakeven Near?

Simply Wall St.
·
16 Oct 2024